Empowered Funds’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Sell
29,640
-7,074
-19% -$162K ﹤0.01% 1610
2026
Q1
$809K Buy
+36,714
New +$639K 0.01% 1483
2025
Q4
Sell
-37,641
Closed -$596K 1150
2025
Q3
$596K Sell
37,641
-18,493
-33% -$268K 0.01% 1342
2025
Q2
$643K Buy
56,134
+26,315
+88% +$297K 0.01% 1230
2025
Q1
$403K Buy
+29,819
New +$495K 0.01% 1305
2024
Q3
Sell
-9,545
Closed -$215K 1402
2024
Q2
$215K Buy
+9,545
New +$250K ﹤0.01% 1280
2023
Q1
Sell
-143,117
Closed -$4.38M 544
2022
Q4
$4.38M Buy
+143,117
New +$4.29M 0.29% 110
2017
Q4
Sell
-15,506
Closed -$785K 96
2017
Q3
$785K Sell
15,506
-580
-4% -$27.4K 0.51% 72
2017
Q2
$610K Sell
16,086
-4,173
-21% -$165K 0.49% 85
2017
Q1
$780K Buy
+20,259
New +$610K 0.8% 44

Other funds holding CC

Empowered Funds's CC Position: Q2 2026 in Review

Empowered Funds reduced its Chemours (CC) stake by 19% in Q2 2026, selling an estimated $162K and leaving 29,640 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Empowered Funds first reported a position in CC in Q1 2017 and has held it in 10 quarters since. The position peaked at $4.38M in Q4 2022. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Empowered Funds held 29,640 shares of Chemours worth $608K as of Q2 2026.
  • Empowered Funds sold 7,074 Chemours shares in Q2 2026, an estimated $162K.
  • Chemours made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1610 holding.
  • Empowered Funds first reported a position in Chemours in Q1 2017 and has held it in 10 quarters since.
  • Empowered Funds's Chemours position peaked at $4.38M in Q4 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.